ArticleMolecular cancer2024

Impact of metronomic trabectedin combined with low-dose cyclophosphamide on sarcoma microenvironment and correlation with clinical outcome: results from the TARMIC study.

Cheng-Ming Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.